LEIDOS BIOMEDICAL RESEARCH INC
Federal contract award, Leidos, $121,524,202
Key CONT_AWD_75N91020F00006_7529_75N91019D00024_7529. First seen by this system September 5, 2026 through the historical sweep, new to the watchlist, public 79 days before this system saw it. One version on record.
Cite this row
On this site https://evidence.ourrevolution.media/filings/leidos/CONT_AWD_75N91020F00006_7529_75N91019D00024_7529
Observed 2026-09-05, version 1, retrieved 2026-09-05T00:54:23Z
Content hash
f0253a3fd31ce051f329b69fa8da78883b7eec211c83e0163b67417d91eee317The source record can change after this date; the key, hash and retrieval time name exactly the response this system stored. See license and citation.
Versions
| Version | Amount | Change | Occurred | Published | Retrieved | How it arrived | Content hash |
|---|---|---|---|---|---|---|---|
| 1 current | $121,524,202 | first version | August 26, 2020 | June 18, 2026 | 2026-09-05T00:54:23Z | historical sweep | f0253a3fd31c |
Archived copy
https://web.archive.org/web/20261009113554/https://www.usaspending.gov/award/CONT_AWD_75N91020F00006_7529_75N91019D00024_7529 captured by this system, October 9, 2026
What the amount is made of
17 recorded actions, so the amount is the award's current total across all of them. 14 of them obligated money. Measured 2026-10-13, when USAspending reported a total obligation of $121,524,202.
| Action date | Modification | Type | Obligated | Description as recorded |
|---|---|---|---|---|
| June 18, 2026 | P00016 | OTHER ADMINISTRATIVE ACTION | −$361 | FY26 UDO INITIATIVE |
| August 16, 2024 | P00015 | OTHER ADMINISTRATIVE ACTION | +$882,401 | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| June 24, 2024 | P00014 | OTHER ADMINISTRATIVE ACTION | +$6,000,000 | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| October 18, 2023 | P00013 | OTHER ADMINISTRATIVE ACTION | no money | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| August 29, 2023 | P00012 | OTHER ADMINISTRATIVE ACTION | +$27,289,181 | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| August 4, 2023 | P00011 | OTHER ADMINISTRATIVE ACTION | +$1,623,831 | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| July 13, 2023 | P00010 | OTHER ADMINISTRATIVE ACTION | +$1,023,492 | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| April 28, 2023 | P00009 | OTHER ADMINISTRATIVE ACTION | +$5,919,518 | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| March 6, 2023 | P00008 | OTHER ADMINISTRATIVE ACTION | +$7,000,000 | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| August 22, 2022 | P00007 | OTHER ADMINISTRATIVE ACTION | +$19,483,497 | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| June 14, 2022 | P00006 | OTHER ADMINISTRATIVE ACTION | +$3,100,000 | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| May 18, 2022 | P00005 | OTHER ADMINISTRATIVE ACTION | no money | NIAID VRC OPERATIONAL TASK ORDER; COVID: VRC IS ENGAGED IN EVALUATING MRNA VACCINES FOR DIFFERENT VARIANTS IN ANIMAL MODELS SO THAT AN EFFECTIVE MRNA VACCINE IS RECOGNIZED. THE MOST EFFECTIVE CONSTRUCTS ARE FURTHER DEVELOPED LEADING TO PRODUCTION UND |
| August 26, 2021 | P00004 | EXERCISE AN OPTION | +$23,062,855 | NIAID VRC |
| July 28, 2021 | P00003 | OTHER ADMINISTRATIVE ACTION | no money | NIAID VACCINE RESEARCH CENTER (VRC) |
| July 23, 2021 | P00002 | OTHER ADMINISTRATIVE ACTION | +$3,664,336 | NIAID VRC |
| July 15, 2021 | P00001 | OTHER ADMINISTRATIVE ACTION | +$500,000 | NIAID VRC |
| August 26, 2020 | base | not on file | +$21,975,452 | NIAID VRC |
Last refreshed November 4, 2026 at 2:31 PM UTC.